Your browser doesn't support javascript.
loading
Probe Electrospray Ionization Tandem Mass Spectrometry for the Detection and Quantification of Benzodiazepines.
Griffeuille, Pauline; El Balkhi, Souleiman; Dulaurent, Sylvain; Saint-Marcoux, Franck.
Afiliación
  • Griffeuille P; Department of Pharmacology and Toxicology, Limoges University Hospital, Limoges ,France ; and.
  • El Balkhi S; Department of Pharmacology and Toxicology, Limoges University Hospital, Limoges ,France ; and.
  • Dulaurent S; Department of Pharmacology and Toxicology, Limoges University Hospital, Limoges ,France ; and.
  • Saint-Marcoux F; Department of Pharmacology and Toxicology, Limoges University Hospital, Limoges ,France ; and.
Ther Drug Monit ; 46(4): 522-529, 2024 Aug 01.
Article en En | MEDLINE | ID: mdl-38498915
ABSTRACT

BACKGROUND:

Legally prescribed benzodiazepines (BZDs) and designer BZDs are widely misused and must be determined in multiple contexts (eg, overdose, drug-facilitated sexual assaults, or driving under the influence of drugs). This study aimed to develop a method for measuring serum BZD levels using probe electrospray ionization (PESI) mass spectrometry and an isotope dilution approach.

METHODS:

A tandem mass spectrometer equipped with a probe electrospray ionization source in multiple reaction monitoring mode was used. Isotope dilution was applied for quantification using a deuterated internal standard at a fixed concentration for alprazolam, bromazepam, diazepam, nordiazepam, oxazepam, temazepam, zolpidem, and zopiclone. This method included designer BZDs clonazolam, deschloroetizolam, diclazepam, etizolam, flualprazolam, flubromazepam, flubromazolam, meclonazepam, nifoxipam, and pyrazolam. Sample preparation was done by mixing 10 µL of serum with 500 µL of an ethanol/ammonium formate 0.01 mol/L buffer. Complete validation was performed, and the method was compared with liquid chromatography coupled with mass spectrometry (LC-MS/MS) and immunoassays (IC) by analyzing 40 real samples.

RESULTS:

The analysis time for identification and quantification of the 18 molecules was 2.5 minutes. This method was fully validated, and the limits of quantification varied from 5 to 50 mcg/L depending on the molecule. In the 40 real samples, 100% of molecules (n = 89) were detected by both LC-MS/MS and PESI-MS/MS, and regression analysis showed excellent agreement between the 2 methods (r 2 = 0.98). On IC, bromazepam and zolpidem were not detected in 2 and 1 cases, respectively.

CONCLUSIONS:

PESI-MS/MS allows serum BZD detection and measurement. Given the isotope dilution approach, a calibration curve was not required, and its performance was similar to that of LC-MS/MS, and its specificity was higher than that of IC.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Benzodiazepinas / Espectrometría de Masa por Ionización de Electrospray / Espectrometría de Masas en Tándem Idioma: En Revista: Ther Drug Monit Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Benzodiazepinas / Espectrometría de Masa por Ionización de Electrospray / Espectrometría de Masas en Tándem Idioma: En Revista: Ther Drug Monit Año: 2024 Tipo del documento: Article